Notably, CRC patients exhibited markedly increased CDP1 (6.3–57.09 μM) and CDP2 (1.09–76.28 μM), while CDP3 remained lower (0.19–40.9 μM). This evidence concerns the gene CUX2 and colorectal carcinoma.